Spots Global Cancer Trial Database for astrocytoma of brain
Every month we try and update this database with for astrocytoma of brain cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma | NCT04091503 | Glioma, Maligna... Gliosarcoma Astrocytoma of ... | Intranasal Modi... | 21 Years - 70 Years | Center Trials & Treatment Europe | |
Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma | NCT04091503 | Glioma, Maligna... Gliosarcoma Astrocytoma of ... | Intranasal Modi... | 21 Years - 70 Years | Center Trials & Treatment Europe | |
Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Astrocytoma | NCT05518994 | Astrocytoma of ... | Tislelizumab pl... | 18 Years - | Henan Provincial People's Hospital | |
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) | NCT06283927 | Glioblastoma Glioblastoma Mu... Glioblastoma, I... Glioblastoma Mu... Glioblastoma Mu... Recurrent Gliob... Astrocytoma, Ma... Astrocytoma of ... | Re-resection Temozolomide Lomustine Re-irradiation Experimental th... Best supportive... | 18 Years - 90 Years | Erasmus Medical Center |